These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35810454)

  • 1. The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited.
    Domenighetti C; Douillard V; Sugier PE; Sreelatha AAK; Schulte C; Grover S; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Gourraud PA; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol JC; Chartier-Harlin MC; Mutez E; Brockmann K; Deutschländer AB; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Duga S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Nakayama A; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; van de Warrenburg BPC; Bloem BR; Aasly J; Toft M; Pihlstrøm L; Correia Guedes L; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Diez-Fairen M; Wirdefeldt K; Pedersen NL; Ran C; Belin AC; Puschmann A; Ygland Rödström E; Clarke CE; Morrison KE; Tan M; Krainc D; Burbulla LF; Farrer MJ; Krüger R; Gasser T; Sharma M; Vince N; Elbaz A;
    Mov Disord; 2022 Sep; 37(9):1929-1937. PubMed ID: 35810454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pooled analysis of the HLA-DRB1 by smoking interaction in Parkinson disease.
    Chuang YH; Lee PC; Vlaar T; Mulot C; Loriot MA; Hansen J; Lill CM; Ritz B; Elbaz A
    Ann Neurol; 2017 Nov; 82(5):655-664. PubMed ID: 28981958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific amino acid motif of
    Hollenbach JA; Norman PJ; Creary LE; Damotte V; Montero-Martin G; Caillier S; Anderson KM; Misra MK; Nemat-Gorgani N; Osoegawa K; Santaniello A; Renschen A; Marin WM; Dandekar R; Parham P; Tanner CM; Hauser SL; Fernandez-Viña M; Oksenberg JR
    Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7419-7424. PubMed ID: 30910980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-Ethnic Fine-Mapping of the Major Histocompatibility Complex Region Linked to Parkinson's Disease.
    Naito T; Satake W; Ogawa K; Suzuki K; Hirata J; Foo JN; Tan EK; Toda T; Okada Y
    Mov Disord; 2021 Aug; 36(8):1805-1814. PubMed ID: 33973677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Parkinson's disease and the HLA-DRB1 locus.
    Ahmed I; Tamouza R; Delord M; Krishnamoorthy R; Tzourio C; Mulot C; Nacfer M; Lambert JC; Beaune P; Laurent-Puig P; Loriot MA; Charron D; Elbaz A
    Mov Disord; 2012 Aug; 27(9):1104-10. PubMed ID: 22807207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DRB1 alleles are associated with the susceptibility to sporadic Parkinson's disease in Chinese Han population.
    Sun C; Wei L; Luo F; Li Y; Li J; Zhu F; Kang P; Xu R; Xiao L; Liu Z; Xu P
    PLoS One; 2012; 7(11):e48594. PubMed ID: 23139797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Parkinson disease with structural and regulatory variants in the HLA region.
    Wissemann WT; Hill-Burns EM; Zabetian CP; Factor SA; Patsopoulos N; Hoglund B; Holcomb C; Donahue RJ; Thomson G; Erlich H; Payami H
    Am J Hum Genet; 2013 Nov; 93(5):984-93. PubMed ID: 24183452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA-DRB1, DQA1 and DQB1 alleles and haplotype in Parkinson's disease from South India.
    Pandi S; Chinniah R; Sevak V; Ravi PM; Raju M; Vellaiappan NA; Karuppiah B
    Neurosci Lett; 2021 Nov; 765():136296. PubMed ID: 34655711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Parkinson's Disease Mendelian Randomization Research Portal.
    Noyce AJ; Bandres-Ciga S; Kim J; Heilbron K; Kia D; Hemani G; Xue A; Lawlor DA; Smith GD; Duran R; Gan-Or Z; Blauwendraat C; Gibbs JR; ; Hinds DA; Yang J; Visscher P; Cuzick J; Morris H; Hardy J; Wood NW; Nalls MA; Singleton AB
    Mov Disord; 2019 Dec; 34(12):1864-1872. PubMed ID: 31659794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Immunochip-based interaction study of contrasting interaction effects with smoking in ACPA-positive versus ACPA-negative rheumatoid arthritis.
    Jiang X; Källberg H; Chen Z; Ärlestig L; Rantapää-Dahlqvist S; Davila S; Klareskog L; Padyukov L; Alfredsson L
    Rheumatology (Oxford); 2016 Jan; 55(1):149-55. PubMed ID: 26272072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-related pathways including HLA-DRB1(∗)13:02 are associated with panic disorder.
    Shimada-Sugimoto M; Otowa T; Miyagawa T; Khor SS; Kashiwase K; Sugaya N; Kawamura Y; Umekage T; Kojima H; Saji H; Miyashita A; Kuwano R; Kaiya H; Kasai K; Tanii H; Okazaki Y; Tokunaga K; Sasaki T
    Brain Behav Immun; 2015 May; 46():96-103. PubMed ID: 25582808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of an α-synuclein epitope with HLA-DRB1
    Garretti F; Monahan C; Sloan N; Bergen J; Shahriar S; Kim SW; Sette A; Cutforth T; Kanter E; Agalliu D; Sulzer D
    Neuron; 2023 Nov; 111(21):3397-3413.e5. PubMed ID: 37597517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by
    Le Guen Y; Luo G; Ambati A; Damotte V; Jansen I; Yu E; Nicolas A; de Rojas I; Peixoto Leal T; Miyashita A; Bellenguez C; Lian MM; Parveen K; Morizono T; Park H; Grenier-Boley B; Naito T; Küçükali F; Talyansky SD; Yogeshwar SM; Sempere V; Satake W; Alvarez V; Arosio B; Belloy ME; Benussi L; Boland A; Borroni B; Bullido MJ; Caffarra P; Clarimon J; Daniele A; Darling D; Debette S; Deleuze JF; Dichgans M; Dufouil C; During E; Düzel E; Galimberti D; Garcia-Ribas G; García-Alberca JM; García-González P; Giedraitis V; Goldhardt O; Graff C; Grünblatt E; Hanon O; Hausner L; Heilmann-Heimbach S; Holstege H; Hort J; Jung YJ; Jürgen D; Kern S; Kuulasmaa T; Lee KH; Lin L; Masullo C; Mecocci P; Mehrabian S; de Mendonça A; Boada M; Mir P; Moebus S; Moreno F; Nacmias B; Nicolas G; Niida S; Nordestgaard BG; Papenberg G; Papma J; Parnetti L; Pasquier F; Pastor P; Peters O; Pijnenburg YAL; Piñol-Ripoll G; Popp J; Porcel LM; Puerta R; Pérez-Tur J; Rainero I; Ramakers I; Real LM; Riedel-Heller S; Rodriguez-Rodriguez E; Ross OA; Royo LJ; Rujescu D; Scarmeas N; Scheltens P; Scherbaum N; Schneider A; Seripa D; Skoog I; Solfrizzi V; Spalletta G; Squassina A; van Swieten J; Sánchez-Valle R; Tan EK; Tegos T; Teunissen C; Thomassen JQ; Tremolizzo L; Vyhnalek M; Verhey F; Waern M; Wiltfang J; Zhang J; ; ; ; ; ; ; ; Zetterberg H; Blennow K; He Z; Williams J; Amouyel P; Jessen F; Kehoe PG; Andreassen OA; Van Duin C; Tsolaki M; Sánchez-Juan P; Frikke-Schmidt R; Sleegers K; Toda T; Zettergren A; Ingelsson M; Okada Y; Rossi G; Hiltunen M; Gim J; Ozaki K; Sims R; Foo JN; van der Flier W; Ikeuchi T; Ramirez A; Mata I; Ruiz A; Gan-Or Z; Lambert JC; Greicius MD; Mignot E
    Proc Natl Acad Sci U S A; 2023 Sep; 120(36):e2302720120. PubMed ID: 37643212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study.
    Larsson SC; Singleton AB; Nalls MA; Richards JB;
    Mov Disord; 2017 Aug; 32(8):1249-1252. PubMed ID: 28594127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the human leucocyte antigen region with susceptibility to Parkinson's disease.
    Saiki M; Baker A; Williams-Gray CH; Foltynie T; Goodman RS; Taylor CJ; Compston DA; Barker RA; Sawcer SJ; Goris A
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):890-1. PubMed ID: 20462916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study.
    Domenighetti C; Sugier PE; Ashok Kumar Sreelatha A; Schulte C; Grover S; Mohamed O; Portugal B; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol JC; Chartier-Harlin MC; Mutez E; Brockmann K; Deutschländer AB; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Duga S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Kawamura Y; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; van de Warrenburg BPC; Bloem BR; Aasly J; Toft M; Pihlstrøm L; Correia Guedes L; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Diez-Fairen M; Wirdefeldt K; Pedersen NL; Ran C; Belin AC; Puschmann A; Hellberg C; Clarke CE; Morrison KE; Tan M; Krainc D; Burbulla LF; Farrer MJ; Krüger R; Gasser T; Sharma M; Elbaz A;
    Mov Disord; 2022 Apr; 37(4):857-864. PubMed ID: 34997937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of human leukocyte antigen-DRB1*15:01 and its interaction with smoking in MS development is dependent on DQA1*01:01 status.
    Hedström AK; Hössjer O; Hillert J; Stridh P; Kockum I; Olsson T; Alfredsson L
    Mult Scler; 2020 Nov; 26(13):1638-1646. PubMed ID: 31573825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking interacts with HLA-DRB1 shared epitope in the development of anti-citrullinated protein antibody-positive rheumatoid arthritis: results from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA).
    Too CL; Yahya A; Murad S; Dhaliwal JS; Larsson PT; Muhamad NA; Abdullah NA; Mustafa AN; Klareskog L; Alfredsson L; Padyukov L; Bengtsson C;
    Arthritis Res Ther; 2012 Apr; 14(2):R89. PubMed ID: 22537824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of HLA-DRB1*09:01 and *04:05 with smoking suggests distinctive mechanisms of rheumatoid arthritis susceptibility beyond the shared epitope.
    Bang SY; Lee HS; Lee KW; Bae SC
    J Rheumatol; 2013 Jul; 40(7):1054-62. PubMed ID: 23637323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers.
    Sugier PE; Lucotte EA; Domenighetti C; Law MH; Iles MM; Brown K; Amos C; McKay JD; Hung RJ; Karimi M; Bacq-Daian D; Boland-Augé A; Olaso R; Deleuze JF; Lesueur F; Ostroumova E; Kesminiene A; de Vathaire F; Guénel P; ; Sreelatha AAK; Schulte C; Grover S; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol JC; Chartier-Harlin MC; Mutez E; Brockmann K; Deutschländer AB; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Nakayama A; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; van de Warrenburg BPC; Bloem BR; Aasly J; Toft M; Pihlstrøm L; Guedes LC; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Diez-Fairen M; Wirdefeldt K; Pedersen N; Ran C; Belin AC; Puschmann A; Rödström EY; Clarke CE; Morrison KE; Tan M; Krainc D; Burbulla LF; Farrer MJ; Kruger R; Gasser T; Sharma M; ; Truong T; Elbaz A
    Mov Disord; 2023 Apr; 38(4):604-615. PubMed ID: 36788297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.